Sanofi Announced Earlier: Hart-Scott-Rodino Waiting Period Expired For Sanofi's Acquisition Of Provention Bio
Author: Charles Gross | April 26, 2023 04:49am
Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), applicable to Sanofi's proposed acquisition of Provention Bio, Inc. (("Provention Bio", NASDAQ:PRVB) has expired.